PRION 2017 CONFERENCE P120 Early preclinical detection of prions in blood of macaques peripherally infected with the variant CJD agent
P120 Early preclinical detection of prions in blood of macaques peripherally infected with the variant CJD
agent.
Luis Concha1,2,Claudio Soto1
1University Of Texas, Houston, United States, 2Universidad de los Andes, Santiago, Chile
Aim: Preclinical detection of prions in blood of experimentally infected non-human primates.
The detection of prions in blood of patients affected by variant Creutzfeldt-Jakob disease (vCJD) has been recently achieved, by means of the protein misfolding cyclic amplification (PMCA) technique (Concha- Marambio et. al., 2016). Moreover, a few blood samples were shown to contain prions before disease onset (Bougard et. al. 2016). However, the unknown time of infection makes impossible to determine when in the incubation period prions can be detected in blood. Thus, we studied blood samples longitudinally collected from 3 macaques infected with the macaque adapted vCJD agent (m-vCJD).
Methods: Three macaques were peripherally infected with m-vCJD (McDowell et. al., 2016). Blood was collected longitudinally, starting 2 months post inoculation (mpi) until the endpoint of the disease. The samples were divided in three panels: early preclinical (2 to 12 mpi), late preclinical (12 mpi to onset) and clinical (onset to final bleed). These samples were kindly provided by Dr Luisa Gregory as de-identified samples.
The PMCA protocol previously used was optimized to detect prions in blood of vCJD patients, for the detection of m-vCJD prions in macaque blood, using human PrP from transgenic mice as substrate. The substrate was supplemented with 100 ug/ml heparin and few modifications were introduced into the PMCA protocol.
Results: m-vCJD prions from macaque brain homogenate (BH) were amplified at similar efficiencies vCJD prions (10-10 to 10-11 dilutions of BH). Prions were readily detected in whole blood, buffy coat and plasma during the clinical phase of the disease. Preclinical samples were more challenging to amplify. However, after PMCA optimization, we could detect with high sensitivity and specificity all the early and late preclinical samples. Our results show that m-vCJD prions from macaque blood can be detected at least ~800 days before the onset of disease.
Conclusions: PMCA was adapted for the efficient amplification of m-vCJD prions present in blood of macaques peripherally challenged with the vCJD agent. Our results suggest that PMCA can detect prions in blood more than 800 days before onset with high sensitivity and specificity. Since the first sample was collected 2 mpi and it was positive, PMCA can probably detect prions in blood weeks after inoculation. Overall, our results show the consistent and reproducible preclinical detection of prions in macaques, which suggest that this protocol could be used in humans for pre-symptomatic detection of carriers infected with vCJD prions.
DISORDERS PRION 2017 DECIPHERING NEURODEGENERATIVE
DISORDERS PRION 2017 DECIPHERING NEURODEGENERATIVE
TUESDAY, JUNE 20, 2017
Prion 2017 Conference Transmissible prions in the skin of Creutzfeldt-Jakob disease patients
WEDNESDAY, MAY 03, 2017
*** First evidence of intracranial and peroral transmission of Chronic Wasting Disease (CWD) into Cynomolgus macaques
FRIDAY, JUNE 16, 2017
PRION 2017 P55 Susceptibility of human prion protein to in vitro conversion by chronic wasting disease prions
MONDAY, JUNE 19, 2017
PRION 2017 P20 Descriptive epidemiology of human prion diseases in Japan: a prospective 16-year surveillance study
Japan Prion Disease Increasing Annually to 2.3 patients per 1 million populations in 2014
TUESDAY, JUNE 13, 2017
PRION 2017 CONFERENCE ABSTRACT Chronic Wasting Disease in European moose is associated with PrPSc features different from North American CWD
SATURDAY, JUNE 10, 2017
Chronic Wasting Disease CWD TSE Prion to Humans, who makes that final call, when, or, has it already happened?
MONDAY, JUNE 19, 2017
PRION 2017 CONFERENCE ABSTRACT P61 vCJD strain properties in a Spanish mother and son replicate as those of a young UK case
WEDNESDAY, JUNE 14, 2017
Amyloid-β accumulation in human growth hormone related iatrogenic CJD patients in the UK
Saturday, June 17, 2017
PRION 2017 P115 α- Synuclein prions from MSA patients exhibit similar transmission properties as PrPSc prions
MONDAY, JUNE 19, 2017
Transmissible Spongiform Encephalopathies Advisory Committee June 2017 CJD, BSE, Scrapie, CWD, TSE, Prion?
WEDNESDAY, JUNE 21, 2017
Docket No. FDA– 2009–N–0505 Agency Information Collection Activities; Proposed Collection; Recordkeeping and Reporting Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing Material From Cattle
THURSDAY, JUNE 22, 2017
World Organisation for Animal Health (OIE) to establish liaison office in College Station, Texas
THURSDAY, DECEMBER 22, 2016
Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease
Tuesday, May 10, 2016
2015 PDA Virus & TSE Safety Forum Meeting Report
>>>Recently transmission of prions from blood of patients with sporadic CJD to humanized mice could be demonstrated.<<<
>>>Further-on, urine samples of a control population (normal and neurological population) showed no signal in the study; *** however, in samples from patients with sporadic CJD and vCJD, a signal was detected in both patient populations.<<<
Meeting Report: 2015 PDA Virus & TSE Safety Forum
Tuesday, March 11, 2014
Science and Technology Committee Oral evidence: Blood, tissue and organ screening, HC 990 Wednesday 5 March 2014 SPORADIC CJD
Actually, it is nearer 2 per million per year of the population will develop sporadic CJD, but your lifetime risk of developing sporadic CJD is about 1 in 30,000. So that has not really changed. When people talk about 1 per million, often they interpret that as thinking it is incredibly rare. They think they have a 1-in-a-million chance of developing this disease. You haven’t. You’ve got about a 1-in-30,000 chance of developing it.
Sunday, March 09, 2014
A Creutzfeldt-Jakob Disease (CJD) Lookback Study: Assessing the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease
*** FDA TSEAC CIRCUS AND TRAVELING ROAD SHOW FOR THE TSE PRION DISEASES ***
Wednesday, December 11, 2013
*** Detection of Infectivity in Blood of Persons with Variant and Sporadic Creutzfeldt-Jakob Disease ***
Wednesday, October 09, 2013
WHY THE UKBSEnvCJD ONLY THEORY IS SO POPULAR IN IT'S FALLACY, £41,078,281 in compensation REVISED
2001 FDA CJD TSE Prion Singeltary Submission
*** U.S.A. 50 STATE BSE MAD COW CONFERENCE CALL Jan. 9, 2001
Terry S. Singeltary Sr.
posted by Terry S. Singeltary Sr. at
2:12 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home